The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: A population-based study

2014 ◽  
Vol 155 (2) ◽  
pp. 1256-1262 ◽  
Author(s):  
Yueh-Ting Tsai ◽  
Jung-Nien Lai ◽  
Chien-Tung Wu
Keyword(s):  
Breast Cancer ◽  
Endometrial Cancer ◽  
Population Based ◽  
Female Breast Cancer ◽  
Breast Cancer Patients ◽  
Population Based Study ◽  
Herbal Products ◽  
Endometrial Cancer Risk ◽  
Chinese Herbal ◽  
Female Breast

scholarly journals Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study

2014 ◽  
Vol 5 (2) ◽  
pp. 151-155 ◽  
Author(s):  
Ju-Yin Chen ◽  
Shou-Jen Kuo ◽  
Yung-Po Liaw ◽  
Itzhak Avital ◽  
Alexander Stojadinovic ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Endometrial Cancer ◽  
Cancer Patients ◽  
Cancer Incidence ◽  
Population Based ◽  
Breast Cancer Patients ◽  
Population Based Study

scholarly journals Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study

PLoS ONE ◽  
2019 ◽  
Vol 14 (9) ◽  
pp. e0222860 ◽  
Author(s):  
Hsin-Hua Chen ◽  
Ching-Heng Lin ◽  
Der-Yuan Chen ◽  
Wen-Cheng Chao ◽  
Yi-Hsing Chen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Autoimmune Diseases ◽  
Cancer Patients ◽  
Population Based ◽  
Female Breast Cancer ◽  
Breast Cancer Patients ◽  
Female Breast

scholarly journals The Prescription Pattern of Chinese Herbal Products ContainingGinsengamong Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Wei-Lung Hsu ◽  
Yueh-Ting Tsai ◽  
Chien-Tung Wu ◽  
Jung-Nien Lai
Keyword(s):  
Breast Cancer ◽  
Endometrial Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Population Based ◽  
Interactive Effects ◽  
Tamoxifen Treatment ◽  
Research Database ◽  
Herbal Products ◽  
Chinese Herbal

Background.The purpose of our study is to analyze the association between prescribed Chinese herbal products (CHPs) containingGinsengand the risk of endometrial cancer among tamoxifen (TMX) users and to identify any possible interactive effects betweenGinsengand TMX with respect to preventing the development of subsequent endometrial cancer in an estrogen-dependent breast cancer population in Taiwan.Methods.All patients newly diagnosed with invasive breast cancer receiving tamoxifen treatment from January 1, 1998, to December 31, 2008, were selected from the National Health Insurance Research Database. The usage, frequency of service, and CHP-Ginsengprescribed across the 30,556 TMX-treated breast cancer (BC) survivors were evaluated. Logistic regression was employed to estimate the odds ratios (ORs) for the utilization of CHP-Ginseng. Cox’s proportional hazard regression was performed to calculate the hazard ratios (HRs) for endometrial cancer associated withGinsenguse among the TMX-treated BC cohort.Results.The HR for the development of endometrial cancer among breast cancer survivors who had ever takenGinsengafter TXM treatment was significantly decreased compared to those who never used CHP.Conclusion.A significant inhibitory relationship betweenGinsengconsumption and subsequent endometrial cancer less than 2 years after TMX treatment was detected among BC survivors.

Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis

2003 ◽  
Vol 108 (5) ◽  
pp. 761-765 ◽  
Author(s):  
Kee Seng Chia ◽  
Wen Bo Du ◽  
R. Sankaranarayanan ◽  
Risto Sankila ◽  
Hao Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Survival Analysis ◽  
Cancer Patients ◽  
Population Based ◽  
Female Breast Cancer ◽  
Breast Cancer Patients ◽  
Female Breast
Sign in / Sign up

Export Citation Format

Share Document